GCC 0442 - A Phase II Study of Evaluation of Cetuximab (Erbitux) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck.
GCC 0448 - A Randomized Phase III Trial Comparing Sequential Therapy With TPF/Chemoradiation (ST) To Cisplatin-Based Chemoradiotherapy with Accelerated Concomitant Boost Radiotherapy (CRT) For Locally Advanced Squamous Cell Cancer of the Head and Neck(Abbreviated Name: The Paradigm Trial)
GCC 0608 - Intra-Tumoral Injection of Dendritic Cells as Adjuvant Therapy for Squamous Cell Carcinoma of the Head and Neck
GCC0781 - A Randomized, Open-Label Phase II Study of BIBW 2992 Versus Cetuximab (Erbitux) in Patients With Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) After Failure of Platinum-Containing Therapy With a Cross-Over Period for Progressing Patients
GCC0938 - Phase II Trial of Dasatinib (BMS 354825) for Recurrent or Metastatic c-KIT Expressing Adenoid Cystic Carcinoma and for Non-Adenoid Cystic Malignant Salivary Tumors
Email this Page
Print this Page
